Related Experiment Video
Updated: Jul 15, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
O(2/3) exposure inhibits cell progression affecting cyclin B1/cdk1 activity in SK-N-SH while induces apoptosis in
A Cannizzaro1, C Verga Verga Falzacappa, M Martinelli
1AFAR-Centro Ricerca S. Pietro, Fatebenefratelli Hospital, Roma, Italy.
Abstract:
In search for innovative therapeutic agents for children neuroblastoma, the oxygen therapy could be considered an alternative anti-tumoral treatment. Given the physiochemical properties of O(2/3) gas mixture including fairly low aqueous solubility and spreading, and the interesting perspective of hyperoxia, we analyzed the inhibitory effect of O(2/3) treatment on two human neuroblastoma cell lines (SK-N-SH and SK-N-DZ). In this study, we demonstrated that O(2/3) treatment was able to induce cell growth inhibition and cell cycle perturbation in both cell lines. We observed an arrest at G(2) phase, accompanied by an alteration in the expression and localization of cyclin B1/cdk1 complex and a reduction in its activity in SK-N-SH cells. This reduction was consistent with the increase in both Wee1 and chk1 protein levels. On the contrary, O(2/3) induced apoptosis in SK-N-DZ cells via caspase 3 activation and Poly ADP-ribose polymerase-1 (PARP) cleavage, associated with an increase in the pro-apoptotic Bax protein. Consequently, we considered the possibility of improving the responsiveness to chemotherapeutic agents such as Cisplatin, Etoposide, and Gemcitabine in combination with O(2/3) treatment. The combined treatments produced a stronger cell inhibitory effect than Cisplatin and Etoposide used alone in SK-N-SH cells. On the contrary, the combination data were not significantly different from O(2/3) treatment alone in SK-N-DZ cells, thus suggesting that the obtained changes in cell growth inhibition were due to the effect of O(2/3) alone.
Insights
Oxygen therapy (O(2/3)) shows promise as an anti-tumoral treatment for neuroblastoma. This study found O(2/3) inhibits neuroblastoma cell growth and induces cell cycle arrest or apoptosis, suggesting potential as a novel therapeutic strategy.
Area of Science:
- Oncology
- Cell Biology
- Biochemistry
Background:
- Neuroblastoma is a significant pediatric cancer, necessitating novel therapeutic approaches.
- Oxygen therapy, particularly hyperoxia, presents an alternative anti-tumoral strategy due to its unique physiochemical properties.
- The efficacy of O(2/3) gas mixture as a treatment for neuroblastoma warrants investigation.
Purpose of the Study:
- To analyze the inhibitory effect of O(2/3) treatment on human neuroblastoma cell lines (SK-N-SH and SK-N-DZ).
- To investigate the mechanisms of O(2/3)-induced cell growth inhibition, including cell cycle perturbation and apoptosis.
- To evaluate the potential of combining O(2/3) treatment with conventional chemotherapeutic agents.
Main Methods:
- Treatment of SK-N-SH and SK-N-DZ neuroblastoma cell lines with O(2/3) gas mixture.
- Analysis of cell growth inhibition, cell cycle progression (G2 arrest), and apoptosis markers (caspase 3, PARP cleavage, Bax).
- Assessment of cyclin B1/cdk1 complex activity, Wee1, and chk1 protein levels.
- Evaluation of combined O(2/3) and chemotherapy (Cisplatin, Etoposide, Gemcitabine) effects.
Main Results:
- O(2/3) treatment inhibited cell growth and induced cell cycle perturbation in both neuroblastoma cell lines.
- In SK-N-SH cells, O(2/3) caused G2 arrest with altered cyclin B1/cdk1 complex activity and increased Wee1/chk1 levels.
- In SK-N-DZ cells, O(2/3) induced apoptosis via caspase 3 activation and PARP cleavage, with increased Bax.
- Combined O(2/3) and chemotherapy showed enhanced inhibition in SK-N-SH cells but not significantly in SK-N-DZ cells.
Conclusions:
- O(2/3) treatment effectively inhibits neuroblastoma cell growth through distinct mechanisms (cell cycle arrest or apoptosis) in different cell lines.
- O(2/3) demonstrates potential as a standalone or combination therapy for neuroblastoma.
- Further research is warranted to optimize O(2/3) therapy for neuroblastoma treatment.
More Related Videos
Related Concept Videos
Inhibition of Cdk Activity
Inhibition of CDK Activity
The Intrinsic Apoptotic Pathway
Positive Regulator Molecules
Positive Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...

